Results 1 to 5 of 5

Thread: WHO concern --- Increasing menace of Cancer in India

  1. #1

    WHO concern --- Increasing menace of Cancer in India

    Concerned at the increasing number of cancer-related deaths, the World Health Organisation (WHO) has suggested prioritizing cancer prevention and control programmes to deal with the menace. The number of cancer-related deaths in India have increased by almost 60% between 1990 and 2013, whereas the new cases of the disease almost doubled during this period, latest estimates show.

    While cancer has already emerged as the second leading cause of death globally after cardiovascular diseases, discussion on how to control the disease burden assumed significance at WHO's South East Asia regional committee meet with focus on the increasing incidence of cancer in developing countries..............

    .........
    According to WHO estimates, 1.1 million deaths and 1.7 million new cases are registered in its South East Asia region every year. India accounts for a major portion with over 1,30,000 mouth cancer cases registered in 2013, the highest in the world; 1,51,304 new breast cancer cases and close to 90,000 new cervical cancer cases.
    History is best when created, better when re-constructed and worst when invented.

  2. The Following User Says Thank You to DrRajpalSingh For This Useful Post:

    rskankara (September 18th, 2015)

  3. #2
    The resolution at WHO called for implementing multi-sectoral actions for "primary prevention of cancer risk factors, in particular tobacco, alcohol and exposure to environmental risk factors". It also highlighted the need to increase public awareness to reduce modifiable risk factors and strengthening community-based interventions.

    Source Link :
    http://go4g.airtel.in/nd/?pid=587303
    History is best when created, better when re-constructed and worst when invented.

  4. #3
    Like everyone else I want to live 1000 years ( wish I would have been a vampire ....)

    I stay away from alcohol and tobacco of any form .......can anyone share what environmental risks are ......I tend to stay away from Smart Phones as well .
    ( read some radiations and stuff some time back )

  5. The Following User Says Thank You to rekhasmriti For This Useful Post:

    DrRajpalSingh (September 13th, 2015)

  6. #4
    We all have some degree of risk.... there are several unknown factors and several passive means.................pollution is one of them.......Air quality of Delhi is worst in world..... Water is another issue (Heavy metals)... vegetables around yamuna khadar....food adulteration....agriculture production uses of pesticides....
    जाट के ठाठ हैं .....

  7. The Following 2 Users Say Thank You to rskankara For This Useful Post:

    DrRajpalSingh (September 19th, 2015), rekhasmriti (October 3rd, 2015)

  8. #5
    Soon, cancer medicines, stents to be cheaper
    Times of India | 19th Sep, 2015 03:03 AM
    [IMG]file:///C:/Users/BRUNOS~1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg[/IMG]NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. .

    The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on margins of companies, a health ministry official told TOI. The government is in talks with pharmaceutical companies to implement the scheme.

    READ ALSO: New cocktails to test limits of cancer drug pricing

    Currently, prices of only 51 cancer medicines are capped or regulated by the government. However, several oncologists, public health experts and even institutes like Tata Memorial Cancer Hospital have advocated bringing in more cancer drugs under price control as these medicines are extremely expensive and often out of reach of majority of patients.

    Following this, the health ministry had planned to bring in more cancer drugs and high-end medical devices like stents directly under price regulation, which would have meant capping their prices. However, the proposal faced strong opposition from the department of pharmaceuticals, which raised concerns about already squeezing margins of manufacturers and a threat to introduction of new drugs in the country.



    After the feedback, the health ministry decided to extend CGHS kind of mechanism to cancer medicines and stents for other consumers also, the official said.

    The new proposal is also likely to work in favour of the industry as not only their margins will be protected through bulk supplies but supplying at a negotiated price will also take care of the threat they face from compulsory licences whereby other ompanies are allowed to produce patented drugs in public interest.

    READ ALSO: Cancer drug spending tops $100 bn globally

    In past few years, several multinationals in India had to face a threat of compulsory licence after generic drug manufacturers claimed that they can make patented oncology and anti-retroviral medicines available at much lower prices. In fact, the first, and so far the only one, compulsory licence granted in India to Natco Pharma was also for a kidney cancer drug Nexavar, originally from Bayer.

    The second application by BDR Pharma seeking CL was also for Bristol-Myers Squibb's cancer drug Dasatinib. Though it was rejected by the Patent Office, a fresh application was subsequently submitted to the Centre under Section 92 of the Patents Act, which allows such licences to be issued under cases of national emergency. A decision is yet to be taken on the application.

    The latest health ministry's proposal is likely to get a final shape by end of this year.

    Currently, the government regulates a total of 348 medicine formulations, prices of which are fixed by the National Pharmaceutical Pricing Authority. Companies are free to price all other medicines but with an annual increase of only up to 10%. In case of stents, there is no price control. The government negotiates prices only for those supplied under CGHS.
    History is best when created, better when re-constructed and worst when invented.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •